glp-1 eye rot Emerging Concerns: Modulators and Their Potential Risk to Vision GLP 1 Blindness Risk |

The med spa owner admitted to using unapproved injectables that sickened at least 10 patients

95% medication adherence in the first month 84% of prescribed patients engage with in-app content 56% use Med Tracker (where side effects can also be tracked) 56% engage in meal logging, with an average of 35 meals logged in the first month Patients log weight 1-2 times per week, on average, over the first 8 weeks of treatment Patients use Noom Move workouts an average of 6.9 times in the first month 45% engage with side-effect support in Nooms Success Kit Noom appreciates the potential of the new PDURS framework because it provides a way to put a software product on the drug label in an evidence-based way

10.1016/j.yclnex.2018.12.004 121 Mashhadi Akbar BoojarM.HassanipourM.Ejtemaei MehrS.Mashhadi Akbar BoojarM.DehpourA

But robust human clinical evidence specifically for disc herniations is still developing